When is JAK inhibitor treatment recommended for alopecia areata?

Alopecia areata is an immune-related condition that can cause smooth patches of hair loss and sometimes involve the scalp more widely, eyebrows, eyelashes, or body hair. A dermatologist checks the pattern, speed of hair loss, nail changes, other autoimmune symptoms, and whether another condition could explain it. JAK inhibitors modify immune signalling and are not appropriate for everyone. The clinician reviews infections, vaccination history, blood-test results, liver or blood problems, clotting concerns, smoking, and other medicines before choosing a treatment.

Arrange a dermatology review and bring a list of medicines, illnesses, infections, and vaccinations. Ask whether tests are needed before treatment and how often follow-up will occur. Take the medicine exactly as prescribed, do not share it, and tell the clinician about fever, persistent cough, shingles exposure, unusual bruising, or new medicines. Protect exposed scalp skin from sun and consider gentle hair care while regrowth is being assessed.

Seek prompt assessment for rapidly spreading hair loss, painful or scarring scalp changes, or loss of eyelashes with eye irritation. While taking a JAK inhibitor, urgently contact the care team for fever or other infection symptoms, chest pain, sudden breathlessness, one-sided leg swelling, severe abdominal pain, or unusual weakness. Do not wait for routine follow-up when these symptoms appear.

Ask how certain the diagnosis is, what extent of hair loss makes a JAK inhibitor reasonable, which tests and vaccines are needed, how infection and clotting risks are managed, and how progress or relapse will be assessed.